By Jonathan Stempel NEW YORK (Reuters) -Consumer Reports on Monday urged four chocolate producers to commit by Valentine’s Day to reduce the amounts of lead and cadmium in their dark chocolate p[...]
Read more
Health
Abbott faces U.S. criminal probe over baby formula -WSJ
(Reuters) -Abbott Laboratories’ Michigan plant, which was at the center of the U.S. baby formula shortage last year, faces a criminal investigation by the Justice Department, the Wall Street Jou[...]
Read more
Insurer ASR to consider sale of bank acquired in Aegon deal, source says
By Pablo Mayo Cerqueiro and Toby Sterling LONDON/AMSTERDAM(Reuters) – Dutch insurer ASR will consider a sale of its banking arm after completing its acquisition of rival Aegon’s domestic o[...]
Read more
U.S. judge grants preliminary approval to Juul consumer settlement
(Reuters) -Juul Labs Inc on Friday secured preliminary court approval of a $255 million settlement resolving claims by consumers that it deceptively marketed e-cigarettes, as the company seeks to reso[...]
Read more
U.S. asks judge to hold Shkreli in contempt for allegedly flouting pharma industry ban
WASHINGTON (Reuters) -U.S. regulators asked a federal judge on Friday to hold Martin Shkreli in contempt for allegedly impeding its efforts to determine whether he flouted a ban on working in the phar[...]
Read more
Canadian insurer Sun Life inks $193 million deal with HK’s Dah Sing
(Reuters) – A unit of Canadian insurer Sun Life Financial Inc has partnered with Hong Kong-based Dah Sing Bank in a deal valued at nearly C$260 million ($193 million), the companies said on Frid[...]
Read more
For Chinese Lunar New Year tourists, retailers roll out rabbit dances, red lanterns
By Chayut Setboonsarng and Farah Master BANGKOK/HONG KONG (Reuters) – As Chinese shoppers trickle back to tourist hotspots for Lunar New Year holidays, malls from Macau to Bangkok aim to lure th[...]
Read more
Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer’s drug
By Deena Beasley (Reuters) -Eli Lilly and Co on Thursday said the U.S. Food and Drug Administration had rejected accelerated approval of its experimental Alzheimer’s drug because it had not subm[...]
Read more
Davos 2023: Trip.com hopes China overseas travel capacity back to normal by Q3
By Brenda Goh DAVOS, Switzerland (Reuters) – Travel website operator Trip.com Group Ltd is working with airlines and airports to encourage recovery in China’s cross-border travel capacity[...]
Read more